Trump confirms new deal with pharmaceutical company Regeneron to lower drug prices
Regeneron agreed to reduce prices for its current and future medications sold to Medicaid, and to lower the price of its cholesterol drug Praluent to $225 for Americans through the TrumpRx.gov website in exchange for relief from pharmaceutical tariffs.
Original Source
Read the full article at Justthenews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.